Trial Profile
The Effect of Benralizumab on Lung Physiology, Exercise-induced Bronchoconstriction and General Health Status: an Exploratory Mechanistic Study
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Dec 2022
Price :
$35
*
At a glance
- Drugs Benralizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 02 Nov 2017 New trial record